Claudin-6-Specific Immunoreceptors And T Cell Epitopes

Patent No. EP3126381 (titled "Claudin-6-Specific Immunoreceptors And T Cell Epitopes") was filed by Biontech Cell&Gene Therapies on Mar 30, 2015. The application was issued on Feb 16, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3126381

BIONTECH CELL&GENE THERAPIES
Application Number
EP15712657A
Filing Date
Mar 30, 2015
Status
Patent Maintained As Amended
Jan 14, 2022
Publication Date
Feb 16, 2022